NCCN 2017 Nursing Program Webinar Series - Clinical Updates and Issues: Bladder Cancer

June 29, 2017

The 2017 NCCN Nursing Program: Advancing Oncology Nursing Live Webinar Series will provide oncology nurses with comprehensive and clinically relevant information to optimize patient education and care. Information is focused on current and critical issues to provide oncology nurses with practical information that can be implemented in the practice setting.

Target Audience

This activity is designed to meet the educational needs of oncology nurses who manage patients with cancer.

Additional information
Supporters: 

This activity is supported by educational grants from Gilead Sciences, Medical Affairs; Pfizer and Taiho Oncology. This activity is supported by educational funding provided by Amgen. This activity is supported by independent educational grants from AbbVie; Incyte; and Merck Co., Inc.

Course summary
Available credit: 
  • 1.00 ANCC contact hours
  • 1.00 Participation
Course opens: 
06/28/2017
Course expires: 
08/29/2017
Event starts: 
06/29/2017 - 11:00am
Event ends: 
06/29/2017 - 12:00pm
Cost:
$0.00

Erika Barrett Meneely, NP
Massachusetts General Hospital Cancer Center

Disclosure of Relevant Financial Relationships
All faculty and activity planners participating in NCCN continuing education activities are expected to disclose any relevant financial relationships with a commercial interest as defined by the ACCME’s, ANCC’s, and ACPE’s Standards for Commercial Support. All faculty presentations have been reviewed for adherence to the ACCME’s Criterion 7: The provider develops activities/educational interventions independent of commercial interests (SCS 1, 2, and 6) by experts on the topics. Full disclosure of faculty relationships will be made prior to the activity.

Nurses
National Comprehensive Cancer Network is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

NCCN designates this educational activity for a maximum of 1.0 contact hour.

Available Credit

  • 1.00 ANCC contact hours
  • 1.00 Participation

Learning Objectives

Following this activity, participants should be able to:

  • Evaluate the clinical utility of immunotherapies in patients with bladder cancer
  • Summarize the adverse events associated the use of immunotherapies in bladder cancer
  • Implement strategies for the prevention and management of treatment-related toxicities

Accreditation Period

Course opens: 
06/28/2017
Course expires: 
08/29/2017

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

To complete this activity, users will need:

  • A device with an Internet connection and sound playback capability
  • Adobe Reader or other PDF reader software for certificate viewing/printing